MDS Announces Senior Management Change
10 Novembre 2006 - 1:00PM
PR Newswire (US)
TORONTO, Nov. 10 /PRNewswire-FirstCall/ -- MDS Inc. (TSX:MDS; NYSE:
MDZ), a global life sciences company, announced today that Jim
Garner, Executive Vice-President Finance and Chief Financial
Officer, will be leaving MDS, effective April 2007. Mr. Garner is
committed to completing the current fiscal year as CFO and to
ensuring a smooth transition before his departure next year to
pursue other career opportunities. "I would like to personally
thank Jim for his commitment and contribution to MDS over his 3
years with the company," said Stephen P. DeFalco, President and
Chief Executive Officer, MDS Inc. "In particular, I appreciate
Jim's support during my first year as CEO and his efforts in
transitioning MDS to a global life sciences company." The company
has initiated an executive search to identify a replacement for Mr.
Garner. About MDS Inc. MDS Inc. (TSX: MDS; NYSE: MDZ) is a global
life sciences company that provides market-leading products and
services that our customers need for the development of drugs and
diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 8,800 highly skilled people in 28 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. MDS Diagnostic Services, a business unit of MDS Inc.
(TSX: MDS, NYSE: MDZ), is a leading provider of laboratory testing
and management services. DATASOURCE: MDS Inc. CONTACT: Investors:
Sharon Mathers, (416) 675-6777 ext. 4721, ; Media: Catherine
Melville, (416) 675-6777 ext. 2265,
Copyright